Effect of routine shoulder X-rays after shoulder arthroplasty on post-operative patient management.
Shoulder X-rays following primary anatomic total shoulder arthroplasty (TSA) lack clinically meaningful impact, according to a study published in the Journal of Shoulder and Elbow Surgery.
Researchers from the University of Virginia Health System in Charlottesville sought to determine medical relevance and cost-benefit of routine radiographs after primary anatomic TSA up to a year postoperatively.
One-hundred sixty patients participated in this study. All underwent anatomic TSA and shoulder radiographs at two weeks, six weeks, four months, and one year postoperatively. Radiographs and clinic notes were assessed to determine if a change in postoperative care happened because of radiographic findings, including postoperative fracture, hardware complication, or any concerning radiographic feature. Cost data and amount billed were obtained.
The results showed normal/unremarkable findings in the majority of radiographs. The reviews yielded no change in management based on these parameters:
The amount billed for radiographs was $284,281 ($1776.76 per patient).
The researchers concluded that there was no clinically meaningful impact from routine postoperative radiography and the procedure did not justify the per-patient expense.
Can AI Facilitate Improved Dual-Energy X-Ray Screening for Patients at High Risk of Osteoporosis?
June 28th 2024Out of 315 patients identified by artificial intelligence (AI) as being at high risk for osteoporosis, subsequent screening with dual-energy X-ray absorptiometry (DXA) in a randomized controlled trial revealed new-onset osteoporosis in 237 patients.
FDA Clears Mobile C-Arm Device Designed for Complex Vascular Procedures
June 17th 2024Offering a combination of intuitive user-friendly controls and enhanced imaging, the Zenition 90 Motorized C-arm reportedly facilitates workflow efficiencies and bolsters visualization for complex vascular procedures, cardiac interventions, and other clinical procedures.
Qure.ai to Debut Multimodality AI Platform for Lung Cancer Imaging at ASCO 2024
May 29th 2024In addition to detecting missed lung nodules on X-rays, the AI-powered Qure.ai lung cancer continuum platform reportedly automates lung nodule measurement on CT scans and facilitates multimodality reporting.